中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
34期
141-142
,共2页
米索前列醇%产后出血%缩宫素%预防
米索前列醇%產後齣血%縮宮素%預防
미색전렬순%산후출혈%축궁소%예방
Misoprostol%Postpartum hemorrhage%Oxytocin%Prevention
目的:探讨米索前列醇与缩宫素联用在产后出血预防方面的临床效果°方法选取2013年5月—2014年5月该院收治的70例自然分娩产妇,随机将其均分为对照组与实验组各35例,娩出胎儿后对照组给予产妇10IU缩宫素静注,实验组在此基础上给予米索前列醇片经舌下含化°观察两组产妇的疗效°结果实验组第三产程(7.4±2.6﹚min,明显短于对照组(15.4±4.0﹚min,差异有统计学意义(P<0.05﹚;实验组产后出血率2.9%,明显少于对照组17.1%,差异有统计学意义(P<0.05﹚;两组不良反应、脉搏和血压变化比较,差异无统计学意义(P>0.05﹚°结论在产后出血预防过程中,联合应用缩宫素和米索前列醇安全有效,可显著降低产后出血率及出血量,安全性高,值得推广应用°
目的:探討米索前列醇與縮宮素聯用在產後齣血預防方麵的臨床效果°方法選取2013年5月—2014年5月該院收治的70例自然分娩產婦,隨機將其均分為對照組與實驗組各35例,娩齣胎兒後對照組給予產婦10IU縮宮素靜註,實驗組在此基礎上給予米索前列醇片經舌下含化°觀察兩組產婦的療效°結果實驗組第三產程(7.4±2.6﹚min,明顯短于對照組(15.4±4.0﹚min,差異有統計學意義(P<0.05﹚;實驗組產後齣血率2.9%,明顯少于對照組17.1%,差異有統計學意義(P<0.05﹚;兩組不良反應、脈搏和血壓變化比較,差異無統計學意義(P>0.05﹚°結論在產後齣血預防過程中,聯閤應用縮宮素和米索前列醇安全有效,可顯著降低產後齣血率及齣血量,安全性高,值得推廣應用°
목적:탐토미색전렬순여축궁소련용재산후출혈예방방면적림상효과°방법선취2013년5월—2014년5월해원수치적70례자연분면산부,수궤장기균분위대조조여실험조각35례,면출태인후대조조급여산부10IU축궁소정주,실험조재차기출상급여미색전렬순편경설하함화°관찰량조산부적료효°결과실험조제삼산정(7.4±2.6﹚min,명현단우대조조(15.4±4.0﹚min,차이유통계학의의(P<0.05﹚;실험조산후출혈솔2.9%,명현소우대조조17.1%,차이유통계학의의(P<0.05﹚;량조불량반응、맥박화혈압변화비교,차이무통계학의의(P>0.05﹚°결론재산후출혈예방과정중,연합응용축궁소화미색전렬순안전유효,가현저강저산후출혈솔급출혈량,안전성고,치득추엄응용°
Objective To investigate the clinical effect of misoprostol combined with oxytocin on preventing postpartum hemor_rhage. Methods 70 puerperants underwent natural labor in our hospital from May 2013 to May 2014 were selected and randomly and equally divided into the control group and the experimental group with 35 cases in each. After the fetus was delivered, the puerperants in the control group were given intravenous injection of oxytocin 10IU, and the puerperants in the experimental group were given sublingual administration of misoprostol tablets based on the treatment given to the control group. And the efficacy of the two groups were observed. Results The third stage of labor of the experimental group was (7.4±2.6) min, obviously shorter than the control group's (15.4±4.0) min (P<0.05);the postpartum hemorrhage rate of the experimental group was 2.9%, significantly less than the control group's 17.1%(P<0.05);there was no significant differences in adverse reactions, pulse and blood pressure changes between the two groups (P>0.05). Conclusion For preventing the postpartum hemorrhage, oxytocin combined with misoprostol can significantly reduce the rate and amount of postpartum hemorrhage with high safety and effectiveness, so it is worthy of promotion and application.